Slope in years of the patient groups for cognitive and gross motor development
| Group . | Cognitive development . | Gross motor development . | ||||
|---|---|---|---|---|---|---|
| β . | SE . | P . | β . | SE . | P . | |
| Asymptomatic | 0.96 | 0.09 | <.001 | 0.69 | 0.09 | <.001 |
| Symptomatic >12 mo | 0.32 | 0.08 | .003 | 0.01 | 0.08 | .87 |
| Symptomatic ≤12 mo | 0.10 | 0.11 | .63 | 0.02 | 0.12 | .87 |
| Untreated | 0.04 | 0.08 | .63 | 0.03 | 0.07 | .64 |
| Group . | Cognitive development . | Gross motor development . | ||||
|---|---|---|---|---|---|---|
| β . | SE . | P . | β . | SE . | P . | |
| Asymptomatic | 0.96 | 0.09 | <.001 | 0.69 | 0.09 | <.001 |
| Symptomatic >12 mo | 0.32 | 0.08 | .003 | 0.01 | 0.08 | .87 |
| Symptomatic ≤12 mo | 0.10 | 0.11 | .63 | 0.02 | 0.12 | .87 |
| Untreated | 0.04 | 0.08 | .63 | 0.03 | 0.07 | .64 |